{"id":"W4200122615","doi":"10.1016/j.annonc.2021.10.132","title":"114TiP KEYNOTE-B99: Phase II study of pembrolizumab plus investigational agents combined with chemotherapy as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC)","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Chemotherapy; Oncology; Lung cancer; Internal medicine; Phases of clinical research; Stage (stratigraphy); Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003574888,0.0002877415,0.001087226,0.0001637641,0.00017909,0.000007492581,0.000202461,0.0001284153,0.0004050804],"category_scores_gemma":[0.0002517999,0.0002285973,0.0001570411,0.0003711934,0.000322691,0.00006563263,0.0001161971,0.0002391958,0.000001282426],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001919149,"about_ca_system_score_gemma":0.002527589,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004844566,"about_ca_topic_score_gemma":0.0007046879,"domain_scores_codex":[0.9977695,0.0001437964,0.0005769078,0.0005042236,0.0005325907,0.0004729317],"domain_scores_gemma":[0.9963109,0.0004202515,0.0004227722,0.0004442409,0.00219252,0.0002093093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3546257,0.1063509,0.09793883,0.007342573,0.02206905,0.002395868,0.07739294,0.006593454,0.1095819,0.001072182,0.1488443,0.06579235],"study_design_scores_gemma":[0.3174,0.2808219,0.04804368,0.0006593653,0.0006512845,0.00004899271,0.004396981,0.003492282,0.2502949,0.0004044392,0.09300417,0.0007819855],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9769284,0.003140227,0.00005764426,0.01626596,0.0001285095,0.002689649,0.0001334845,0.0000267786,0.0006293249],"genre_scores_gemma":[0.9860033,0.004654491,0.0004487699,0.005262734,0.0001772033,0.000612038,0.00008343542,0.00005616067,0.002701878],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.174471,"threshold_uncertainty_score":0.9321927,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1475345320760051,"score_gpt":0.4615941176671869,"score_spread":0.3140595855911819,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}